MAM
Ashwini Dhingra joins DDB Mudra
MUMBAI: Ashwini Dhingra has been appointed DDB Mudra Delhi SVP and will report directly to DDB Mudra Group Delhi president Vandana Das. He will be handling some of the agency‘s Delhi-based clients such as Dabur, HBO, Jaypee Group, PepsiCo, Twinings and Wrigley‘s.
Dhingra‘s previous stint was with JWT Kolkata where he was vice president and director client services. He started his career in 1990 with Specialty Papers and shifted to advertising in 1997 with Euro RSCG where he worked for 14 years before joining JWT in 2011. In his tenure of 15 years, Dhingra has worked with Essar Cellphone, Lacoste, Kohler, Lebon, IMT, Jaypee Group, Zee News, ITC, Mayur Plywood and Tata Steel to name a few.
DDB Mudra Group CEO and managing director Madhukar Kamath said, “For the DDB Mudra Group, Delhi is the growth market. Our offerings – advertising, media, digital, CRM, experiential, shopper marketing, retail and strategic branding enable us to deliver to a varied client portfolio. In line with our strategy to grow in Delhi, which already accounts for close to 40 per cent of the DDB Mudra Group businesses, we are further strengthening the team with Ashwini who comes to us from JWT. We now have a terrific team in place spearheaded by Vandana.”
Das said, “Over the past few months, the team in Delhi has gotten stronger. We‘ve got Radhika Das, Xavi, Ravinder Siwach, Nagendra Choudhary and now Ashwini on board. All of them are experts in their respective fields and I feel truly privileged to lead such a talented team.”
Dhingra said, “It is a fantastic opportunity to join an agency focussed to touch newer heights and I am looking forward to adding value by teaming-up with one of the best talents of the advertising industry.”
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
